Senior insider sale
President and CEO at ENANTA PHARMACEUTICALS INC — senior position signals high conviction
$67.5K
4.74K shares
What this filing means
LULY JAY R. plans to sell 4.74K shares of ENANTA PHARMACEUTICALS INC valued at approximately $67.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/5/2025ACC: 0001571211-25-000003
DirectorOfficer· President and CEO
Since Jul 2018
4.74K
Shares to sell
$67.5K
Approx. market value
15.75K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
12/4/2025
15.75KTotal acquired15.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/4/2025 | Restricted Stock Unit Vesting Compensation | 15.75K | — |
| Total | 15.75K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
4.74K
Market value
$67.5K
12/5/2025
Total
Units
4.74K
Value
$67.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/5/2025 | 4.74K | $67.5K | Nasdaq | Planned |
| Total | 4.74K | $67.5K | ||